These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33882287)

  • 1. Donor-specific ELISPOT assay for predicting acute rejection and allograft function after kidney transplantation: A systematic review and meta-analysis.
    Udomkarnjananun S; Kerr SJ; Townamchai N; van Besouw NM; Hesselink DA; Baan CC
    Clin Biochem; 2021 Aug; 94():1-11. PubMed ID: 33882287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
    Gandolfini I; Crespo E; Baweja M; Jarque M; Donadei C; Luque S; Montero N; Allesina A; Perin L; Maggiore U; Cravedi P; Bestard O
    PLoS One; 2018; 13(7):e0200696. PubMed ID: 30059561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-Linked Immunosorbent Spot (ELISpot) monitoring of cytokine-producing cells for the prediction of acute rejection in renal transplant patients.
    Mohammadi F; Solgi G; Tajik M; Ahmadpoor P; Nikoeinejad H; Einollahi B; Nazari B; Lessan-Pezeshki M; Amirzargar A
    Eur Cytokine Netw; 2017 Sep; 28(3):93-101. PubMed ID: 29187340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft.
    Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I
    Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of enzyme-linked immunosorbent spot (ELISPOT) assay for BK polyomavirus immune response monitoring after kidney transplantation.
    Udomkarnjananun S; Kerr SJ; Francke MI; Avihingsanon Y; van Besouw NM; Baan CC; Hesselink DA
    J Clin Virol; 2021 Jul; 140():104848. PubMed ID: 33979739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17 ELISpot as Predictor for Kidney Allograft Rejection?
    Lindemann M; Könemann J; Horn PA; Witzke O
    Clin Lab; 2016; 62(5):963-5. PubMed ID: 27349025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.
    Nickel P; Presber F; Bold G; Biti D; Schönemann C; Tullius SG; Volk HD; Reinke P
    Transplantation; 2004 Dec; 78(11):1640-6. PubMed ID: 15591953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients.
    Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK
    Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients.
    Lindemann M; Korth J; Sun M; Xu S; Struve C; Werner K; Dornieden T; Horn PA; Witzke O; Wilde B
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cellular sensitization and donor age on acute rejection and graft function after deceased-donor kidney transplantation.
    Hricik DE; Poggio ED; Woodside KJ; Sarabu N; Sanchez EQ; Schulak JA; Padiyar A; Heeger PS; Augustine JJ
    Transplantation; 2013 May; 95(10):1254-8. PubMed ID: 23603792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients.
    Augustine JJ; Siu DS; Clemente MJ; Schulak JA; Heeger PS; Hricik DE
    Am J Transplant; 2005 Aug; 5(8):1971-5. PubMed ID: 15996247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of cellular immunity by interferon-gamma enzyme-linked immunosorbent spot assay in kidney allograft recipients: preliminary results of a longitudinal study.
    Bellisola G; Tridente G; Nacchia F; Fior F; Boschiero L
    Transplant Proc; 2006 May; 38(4):1014-7. PubMed ID: 16757248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots.
    Augustine JJ; Poggio ED; Heeger PS; Hricik DE
    Transplantation; 2008 Aug; 86(4):529-34. PubMed ID: 18724221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.
    Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P
    Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.
    Bestard O; Crespo E; Stein M; Lúcia M; Roelen DL; de Vaal YJ; Hernandez-Fuentes MP; Chatenoud L; Wood KJ; Claas FH; Cruzado JM; Grinyó JM; Volk HD; Reinke P
    Am J Transplant; 2013 Jul; 13(7):1880-90. PubMed ID: 23763435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine antigen-specific IFN-γ ELISpot as a potentially valuable tool for monitoring cellular immune responses in pig-to-non-human primate islet xenotransplantation.
    Kim HJ; Yoon IH; Min BH; Kim YH; Shin JS; Kim JM; Kim JS; Nam HY; Lee WW; Park CG
    Xenotransplantation; 2016 Jul; 23(4):310-9. PubMed ID: 27464486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17.
    Faddoul G; Nadkarni GN; Bridges ND; Goebel J; Hricik DE; Formica R; Menon MC; Morrison Y; Murphy B; Newell K; Nickerson P; Poggio ED; Rush D; Heeger PS;
    Transplantation; 2018 Apr; 102(4):673-680. PubMed ID: 29189482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplantation cellular alloreactivity is predictive of acute graft rejection and 1-year graft function in kidney transplant recipients.
    Koscielska-Kasprzak K; Drulis-Fajdasz D; Kaminska D; Mazanowska O; Krajewska M; Gdowska W; Bieniecki W; Chudoba P; Polak W; Janczak D; Patrzalek D; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3006-8. PubMed ID: 19857662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection.
    van Besouw NM; Yan L; de Kuiper R; Klepper M; Reijerkerk D; Dieterich M; Roelen DL; Claas FHJ; Clahsen-van Groningen MC; Hesselink DA; Baan CC
    Front Immunol; 2019; 10():748. PubMed ID: 31024571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.